UB Paderborn / Katalog / Suche / in CDI

PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis

Oncogene, 2008-03, Vol.27 (14), p.2004-2014

2008

Volltextzugriff (PDF)

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-10, Vol.373 (17), p.1627-1639

2015

Volltextzugriff (PDF)

MA15.08 Multicenter Phase II Trial of LN-145 TIL Cell Therapy plus Pembrolizumab in Patients with ICI-Naïve Metastatic NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S155

2023

Volltextzugriff (PDF)

883TiP A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC

Annals of oncology, 2022-09, Vol.33, p.S952

2022

Volltextzugriff (PDF)

1086MO Lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced mucosal melanoma after progression on immune checkpoint inhibitors (ICI): Results from the phase II C-144-01 study

Annals of oncology, 2023-10, Vol.34, p.S654-S654

2023

Volltextzugriff (PDF)

EP08.01-110 Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in mNSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S395-S396

2022

Volltextzugriff (PDF)

188TiP A phase II multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic non-small cell lung cancer (mNSCLC)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S800-S800

2021

Volltextzugriff (PDF)

844P Efficacy and safety of lifileucel, an investigational autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma previously treated with anti-LAG3 antibody

Annals of oncology, 2022-09, Vol.33, p.S935-S936

2022

Volltextzugriff (PDF)

P14.05 Phase 2, Study of Iovance Autologous Tumor Infiltrating Lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) In Patients With Solid Tumors

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1012-S1013

2021

Volltextzugriff (PDF)

P14.04 A Phase 2 Multicenter Study of Iovance Autologous Tumor Infiltrating Lymphocytes (TIL, LN-145) Cell Therapy in Patients With Metastatic NSCLC

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1012-S1012

2021

Volltextzugriff (PDF)

187TiP Phase II, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumours

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S799-S800

2021

Volltextzugriff (PDF)

119O Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study

Immuno-oncology technology, 2023-12, Vol.20, p.100591, Article 100591

2023

Volltextzugriff (PDF)

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG

Klinische Pädiatrie, 2002-07, Vol.214 (4), p.206-211

2002

Volltextzugriff (PDF)

Effect of IGF-1R inhibitor BMS-754807 on tumor glucose metabolism and proliferation in Sal-IGF xenografts by FDG and FLT- PET imaging

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14501-e14501

2009

Volltextzugriff (PDF)

412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors

European journal of cancer supplements, 2010, Vol.8 (7), p.131-131

2010

Volltextzugriff (PDF)

Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG

Klinische Pädiatrie, 2002-07, Vol.214 (4), p.206

2002

Volltextzugriff (PDF)

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG

Klinische Pädiatrie, 2002-07, Vol.214 (4), p.206-211

2002

Volltextzugriff (PDF)

Untersuchung des N-myc Status beim Neuroblastom aus Knochenmarkzellen

Klinische Pädiatrie, 1991-07, Vol.203 (4), p.323-327

1991

Volltextzugriff (PDF)

Untersuchung des N-myc Status beim Neuroblastom aus Knochenmarkzellen

Klinische Pädiatrie, 1991-07, Vol.203 (4), p.323-327

1991

Volltextzugriff (PDF)

Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24), p.7597-7607

2011

Volltextzugriff (PDF)

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (12), p.893-898

2002

Volltextzugriff (PDF)

Abstract 363: Therapeutic targeting of insulin receptor-A with a dual IGF-1R/IR inhibitor: Overcoming a potential escape mechanism from IGF-1R-specific signaling inhibition in insulin receptor-A transfected cancer cells

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.363-363

2010

Volltextzugriff (PDF)

Bone Marrow Transplantation in Hemophagocytic Lymphohistiocytosis

Leukemia & lymphoma, 2001-03, Vol.41 (1-2), p.89-95

2001

Volltextzugriff (PDF)

Detection of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma using the reverse transcriptase-polymerase chain reaction

Genes chromosomes & cancer, 1996-08, Vol.16 (4), p.254-260

1996

Volltextzugriff (PDF)

Difference Methods for Quasilinear 2D-diffusion Problems in Toroidal Configurations

Mathematical methods in the applied sciences, 1997-04, Vol.20 (6), p.477-493

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

MA15.08 Multicenter Phase II Trial of LN-145 TIL Cell Therapy plus Pembrolizumab in Patients with ICI-Naïve Metastatic NSCLC

883TiP A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC

1086MO Lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced mucosal melanoma after progression on immune checkpoint inhibitors (ICI): Results from the phase II C-144-01 study

EP08.01-110 Trial in Progress: A Phase 2 Multicenter Study (IOV-LUN-202) of Autologous Tumor-infiltrating Lymphocyte (TIL) Cell Therapy (LN-145) in mNSCLC

188TiP A phase II multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic non-small cell lung cancer (mNSCLC)

844P Efficacy and safety of lifileucel, an investigational autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma previously treated with anti-LAG3 antibody

P14.05 Phase 2, Study of Iovance Autologous Tumor Infiltrating Lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) In Patients With Solid Tumors

P14.04 A Phase 2 Multicenter Study of Iovance Autologous Tumor Infiltrating Lymphocytes (TIL, LN-145) Cell Therapy in Patients With Metastatic NSCLC

187TiP Phase II, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumours

119O Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG

Effect of IGF-1R inhibitor BMS-754807 on tumor glucose metabolism and proliferation in Sal-IGF xenografts by FDG and FLT- PET imaging

412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors

Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG

Untersuchung des N-myc Status beim Neuroblastom aus Knochenmarkzellen

Untersuchung des N-myc Status beim Neuroblastom aus Knochenmarkzellen

Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

Abstract 363: Therapeutic targeting of insulin receptor-A with a dual IGF-1R/IR inhibitor: Overcoming a potential escape mechanism from IGF-1R-specific signaling inhibition in insulin receptor-A transfected cancer cells

Bone Marrow Transplantation in Hemophagocytic Lymphohistiocytosis

Detection of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma using the reverse transcriptase-polymerase chain reaction

Difference Methods for Quasilinear 2D-diffusion Problems in Toroidal Configurations

Suchergebnisse filtern